Search Results - "Miljković, Miloš D."

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study by Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D, Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H, Slansky, Adam, Vu, Tuan, Jewell, Christopher M, Singer, Michael S, Kalayoglu, Murat V, Howard, James F, Mozaffar, Tahseen, Granit, Volkan, Benatar, Michael, Mozaffar, Tahseen, Chahin, Nizar, Howard, James F., Slansky, Adam D., Feinberg, Marc H., Sahagian, Gregory, Vu, Tuan, Pereira, Denise, Steele, Julie, Paredes, Maria Elena, Benjamin, Cara, Komanduri, Krishna, Habib, Ali Aamer, Fong, Julia Kimberly, De La Cruz, Luis, Dimitrova, Diana, Chopra, Manisha, Holley, Kelly, DeMaria, Gabrielle, Tenorio, April, Requena, Naraly, Brooks, Beverly Mackanzie, Suresh, Niraja, Farias, Jerrica, Miljković, Miloš D, Kurtoglu, Metin, Ngo Casi, Minhtran, Chowdhury, Adam, Kamboh, Hafsa, Stewart, C Andrew, Tosun, Mehmet, Shan, Yufei, Daniel, Shaji, Duvernay, Matthew T., Kireeva, Maria, English, Emily, Jewell, Christopher M., Singer, Michael S, Kalayoglu, Murat V

“…Chimeric antigen receptor (CAR) T cells are highly effective in treating haematological malignancies, but associated toxicities and the need for…”
Get full text

Engineering CAR-T therapies for autoimmune disease and beyond by English, Emily P, Swingler, Rachel N, Patwa, Simran, Tosun, Mehmet, Howard, Jr, James F, Miljković, Miloš D, Jewell, Christopher M

“…Chimeric antigen receptor-T cell (CAR-T) therapy has transformed the management of refractory hematological malignancies. Now that targeting pathogenic cells…”
Get more information

Picosecond spectral coherent anti-Stokes Raman scattering imaging with principal component analysis of meibomian glands by Lin, Chia-Yu, Potma, Eric O, Suhalim, Jeffrey L, Nien, Chyong Ly, Jester, James V, Miljkovic, Milo D, Diem, Max

“…The lipid distribution in the mouse meibomian gland was examined with picosecond spectral anti-Stokes Raman scattering (CARS) imaging. Spectral CARS data sets…”
Get full text

Paxlovid: A Regulatory Gamble by Miljković, Miloš D., Prasad, Vinay

Get full text

Role of CCL19/21 and its possible signaling through CXCR3 in development of metallophilic macrophages in the mouse thymus by Milićević, Novica M., Miljković, Miloš D., Milićević, Živana, Labudović-Borović, Milica, Wang, Xiaoping, Laan, Martti, Peterson, Pärt, Randall, Troy D., Westermann, Jürgen

“…We have already shown that metallophilic macrophages, which represent an important component in the thymus physiology, are lacking in lymphotoxin-β…”
Get full text

Metallophilic macrophages are fully developed in the thymus of autoimmune regulator (Aire)-deficient mice by Milićević, Novica M, Milićević, Živana, Miljković, Miloš D, Labudović-Borović, Milica, Laan, Martti, Peterson, Pärt, Kisand, Kai, Scott, Hamish S, Qu, Ning, Westermann, Jürgen

“…Thymic metallophilic macrophages represent a significant component in the thymus physiology. Recently, we showed their presence to be dependent on functional…”
Get full text

Morphometric study of healthy jejunal and ileal mucosa in adult and aged subjects by Trbojević-Stanković, Jasna B, Milićević, Novica M, Milosević, Dragoslav P, Despotović, Nebojsa, Davidović, Mladen, Erceg, Predrag, Bojić, Bozidar, Bojić, Danijela, Svorcan, Petar, Protić, Marijana, Dapcević, Branka, Miljković, Milos D, Milićević, Zivana

“…Small intestine mucosa is often affected with malabsorptive, autoimmune and inflammatory pathological processes. However, morphometric data on the healthy…”
Get full text

Transforming bioengineering with unbiased teams and tools by Jewell, Christopher M, Miljković, Miloš D, Oakes, Robert S

“…Scientific bias originates from both researchers and techniques. Evidence-based strategies to mitigate this bias include the assembly of diverse teams,…”
Get full text

Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018 by DeMartino, Patrick C, Miljkovic, Miloš D, Prasad, Vinay

“…The growth of cancer drug spending in the US has outpaced spending in nearly all other sectors, and an increasing proportion of the drug development pipeline…”
Get more information

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020 by Miljkovic, Miloš D, Tuia, Jordan E, Olivier, Timothée, Haslam, Alyson, Prasad, Vinay

Get more information

IL-15 in the Combination Immunotherapy of Cancer by Waldmann, Thomas A, Dubois, Sigrid, Miljkovic, Milos D, Conlon, Kevin C

“…We completed clinical trials of rhIL-15 by bolus, subcutaneous, and continuous intravenous infusions (CIV). IL-15 administered by CIV at 2 mcg/kg/day yielded a…”
Get full text

Identifying potential factors of variable response to mogamulizumab in adult T-cell leukemia/lymphoma between Japanese and other populations by Janakiram, Murali, Miljkovic, Milos D

Get full text

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making by Melani, Christopher, Advani, Ranjana, Roschewski, Mark, Walters, Kelsey M, Chen, Clara C, Baratto, Lucia, Ahlman, Mark A, Miljkovic, Milos D, Steinberg, Seth M, Lam, Jessica, Shovlin, Margaret, Dunleavy, Kieron, Pittaluga, Stefania, Jaffe, Elaine S, Wilson, Wyndham H

“…Dose-adjusted-EPOCH-R obviates the need for radiotherapy in most patients with primary mediastinal B-cell lymphoma. End-of-treatment PET, however, does not…”
Get full text

Cancer Drug Price and Novelty in Mechanism of Action by Miljkovic, Miloš D, Tuia, Jordan, Olivier, Timothée, Haslam, Alyson, Prasad, Vinay

“…Many economic theories point to regulatory issues and subsidization of research and development costs as the primary factor in the high cancer drug prices in…”
Get full text

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies by Dubois, Sigrid P, Miljkovic, Milos D, Fleisher, Thomas A, Pittaluga, Stefania, Hsu-Albert, Jennifer, Bryant, Bonita R, Petrus, Michael N, Perera, Liyanage P, Müller, Jürgen R, Shih, Joanna H, Waldmann, Thomas A, Conlon, Kevin C

“…BackgroundFull application of cytokines as oncoimmunotherapeutics requires identification of optimal regimens. Our initial effort with intravenous bolus…”
Get full text

"Allow Natural Death" versus "Do Not Resuscitate": What Do Patients with Advanced Cancer Choose? by Miljković, Miloš D, Emuron, Dennis, Rhodes, Lori, Abraham, Joseph, Miller, Kenneth

“…Many patients with advanced cancer at our hospital request full resuscitative efforts at the end of life. We assessed the knowledge and attitudes of these…”
Get more information

Cytokines in the Treatment of Cancer by Conlon, Kevin C, Miljkovic, Milos D, Waldmann, Thomas A

“…Cytokines are major regulators of innate and adaptive immunity that enable cells of the immune system to communicate over short distances. Cytokine therapy to…”
Get more information

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia by Daenthanasanmak, Anusara, Lin, Yuquan, Zhang, Meili, Bryant, Bonita R., Petrus, Michael N., Bamford, Richard N., Thomas, Craig J., Miljkovic, Milos D., Conlon, Kevin C., Waldmann, Thomas A.

“…•IL-2Rα is expressed in the leukemic cells of smoldering/chronic ATL patients, leading to activation of the JAK/STAT pathway.•JAK1 inhibition with Upadacitinib…”
Get full text

Safety and Efficacy of Autologous RNA Chimeric Antigen Receptor T-cell (rCAR-T) Therapy in Myasthenia Gravis: a prospective, multicenter, open-label, non-randomised phase 1b/2a study by Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D., Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H., Slansky, Adam, Vu, Tuan, Jewell, Christopher M., Singer, Michael S., Kalayoglu, Murat V., Howard, James F., Mozaffar, Tahseen

Get full text

Patterns of Radiation-Associated Lymphopenia in Children with Cancer by Miljković, Miloš D, Grossman, Stuart A, Ye, Xiaobu, Ellsworth, Susannah, Terezakis, Stephanie

“…Adults with cancer commonly develop severe lymphopenia two months following chemoradiation therapy, which is an independent predictor of survival. In this…”
Get full text